IMPRIMISRX Trademark

Trademark Overview

On Friday, February 6, 2015, a trademark application was filed for IMPRIMISRX with the United States Patent and Trademark Office. The USPTO has given the IMPRIMISRX trademark a serial number of 86527531. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, June 23, 2022. This trademark is owned by Imprimis Pharmaceuticals, Inc.. The IMPRIMISRX trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Pharmaceutical compounding services
imprimisrx

General Information

Serial Number86527531
Word MarkIMPRIMISRX
Filing DateFriday, February 6, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, June 23, 2022
Registration Number4890493
Registration DateTuesday, January 19, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 5, 2015

Trademark Statements

Pseudo MarkIMPRIMIS RX
Goods and ServicesPharmaceutical compounding services

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, February 21, 2015
Primary Code044
First Use Anywhere DateSaturday, January 31, 2015
First Use In Commerce DateSaturday, January 31, 2015

Trademark Owner History

Party NameHARROW IP, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressNASHVILLE, TN 37205
Party NameImprimis Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameImprimis Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameImprimis Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Wednesday, February 7, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, April 12, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, June 23, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, June 23, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, June 22, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 18, 2022TEAS SECTION 8 & 15 RECEIVED
Tuesday, January 19, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 27, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 27, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 27, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 27, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, August 2, 2017ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, January 19, 2016REGISTERED-PRINCIPAL REGISTER
Friday, December 18, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, December 17, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, December 17, 2015STATEMENT OF USE PROCESSING COMPLETE
Tuesday, November 17, 2015USE AMENDMENT FILED
Friday, December 11, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 17, 2015TEAS STATEMENT OF USE RECEIVED
Tuesday, June 30, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 5, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 5, 2015PUBLISHED FOR OPPOSITION
Wednesday, April 15, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, March 28, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, March 28, 2015ASSIGNED TO LIE
Monday, March 9, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 3, 2015ASSIGNED TO EXAMINER
Tuesday, February 24, 2015NOTICE OF PSEUDO MARK E-MAILED
Saturday, February 21, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 10, 2015NEW APPLICATION ENTERED

Related Keywords

imprimisrx services compounding pharmaceutical